Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 3,546 | 1,373 | 1,352 | 2,751 | 1,015 |
| Operating Income | -3,546 | -1,373 | -1,352 | 4,958 | -1,015 |
| Other Income | 15 | 1 | 1 | 8 | 2 |
| Pre-tax Income | -3,531 | -1,373 | -1,352 | 4,966 | -1,013 |
| Income Tax | -55 | 0 | 0 | 1 | 0 |
| Net Income Continuous | -3,475 | -1,372 | -1,352 | 4,966 | -1,013 |
| Net Income | $-3,475 | $-1,372 | $-1,352 | $4,966 | $-1,013 |
| EPS Basic Total Ops | -6.63 | -5.27 | -5.10 | 18.71 | -3.91 |
| EPS Basic Continuous Ops | -6.63 | -5.24 | -5.16 | 19.03 | -3.87 |
| EPS Diluted Total Ops | -6.63 | -5.27 | -5.10 | 18.71 | -3.91 |
| EPS Diluted Continuous Ops | -6.63 | -5.24 | -5.16 | 19.03 | -3.87 |
| EBITDA(a) | $-3,541 | $-1,368 | $-1,347 | $-2,740 | $-993 |